Macro Finance
Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers
Bloomberg Markets·September 8, 2026·1 min read
Novartis shares fell after its third clinical-trial setback in a week, as a treatment for a rare muscle-wasting disease failed a late-stage study. Boston Scientific dropped on cybersecurity fallout impacting shipments and missing estimates. Intel rose on reports of upcoming chip price hikes.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.